GURUFOCUS.COM » STOCK LIST » Healthcare » Medical Diagnostics & Research » Dr Lalchandani Labs Ltd (BOM:541299) » Definitions » Price-to-Owner-Earnings

Dr Lalchandani Labs (BOM:541299) Price-to-Owner-Earnings : (As of Jun. 20, 2024)


View and export this data going back to 2018. Start your Free Trial

What is Dr Lalchandani Labs Price-to-Owner-Earnings?

As of today (2024-06-20), Dr Lalchandani Labs's share price is ₹20.15. Dr Lalchandani Labs does not have enough data to calculate Owner Earnings per Share (TTM), so as pPrice-to-Owner-Earnings.


The historical rank and industry rank for Dr Lalchandani Labs's Price-to-Owner-Earnings or its related term are showing as below:

During the past 12 years, the highest Price-to-Owner-Earnings of Dr Lalchandani Labs was 57.27. The lowest was 10.27. And the median was 18.10.


BOM:541299's Price-to-Owner-Earnings is not ranked *
in the Medical Diagnostics & Research industry.
Industry Median: 24.48
* Ranked among companies with meaningful Price-to-Owner-Earnings only.

As of today (2024-06-20), Dr Lalchandani Labs's share price is ₹20.15. Dr Lalchandani Labs's Earnings per Share (Diluted) for the trailing twelve months (TTM) ended in Mar. 2024 was ₹1.43. Therefore, Dr Lalchandani Labs's PE Ratio for today is 14.09.

As of today (2024-06-20), Dr Lalchandani Labs's share price is ₹20.15. Dr Lalchandani Labs's EPS without NRI for the trailing twelve months (TTM) ended in was ₹-1.38. Therefore, Dr Lalchandani Labs's PE Ratio without NRI for today is At Loss.

During the past 12 years, Dr Lalchandani Labs's highest PE Ratio without NRI was 49.50. The lowest was 0.00. And the median was 12.30.


Dr Lalchandani Labs Price-to-Owner-Earnings Historical Data

The historical data trend for Dr Lalchandani Labs's Price-to-Owner-Earnings can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Dr Lalchandani Labs Price-to-Owner-Earnings Chart

Dr Lalchandani Labs Annual Data
Trend Mar15 Mar16 Mar17 Mar18 Mar19 Mar20 Mar21 Mar22 Mar23 Mar24
Price-to-Owner-Earnings
Get a 7-Day Free Trial Premium Member Only Premium Member Only - 16.85 15.19 - -

Dr Lalchandani Labs Semi-Annual Data
Mar13 Mar14 Mar15 Mar16 Mar17 Sep17 Mar18 Sep18 Mar19 Sep19 Mar20 Sep20 Mar21 Sep21 Mar22 Sep22 Mar23 Sep23 Mar24
Price-to-Owner-Earnings Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only 15.19 - - - -

Competitive Comparison of Dr Lalchandani Labs's Price-to-Owner-Earnings

For the Diagnostics & Research subindustry, Dr Lalchandani Labs's Price-to-Owner-Earnings, along with its competitors' market caps and Price-to-Owner-Earnings data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.


Dr Lalchandani Labs's Price-to-Owner-Earnings Distribution in the Medical Diagnostics & Research Industry

For the Medical Diagnostics & Research industry and Healthcare sector, Dr Lalchandani Labs's Price-to-Owner-Earnings distribution charts can be found below:

* The bar in red indicates where Dr Lalchandani Labs's Price-to-Owner-Earnings falls into.



Dr Lalchandani Labs Price-to-Owner-Earnings Calculation

In 1986 Berkshire Hathaway Shareholder Letter, Warren Buffett defined owner earnings as follows:

"These represent (a) reported earnings plus (b) depreciation, depletion, amortization, and certain other non-cash charges...less (c) the average annual amount of capitalized expenditures for plant and equipment, etc. that the business requires to fully maintain its long-term competitive position and its unit volume. (If the business requires additional working capital to maintain its competitive position and unit volume, the increment also should be included in (c))...Our owner-earnings equation does not yield the deceptively precise figures provided by GAAP, since (c) must be a guess - and one sometimes very difficult to make. Despite this problem, we consider the owner earnings figure, not the GAAP figure, to be the relevant item for valuation purposes - both for investors in buying stocks and for managers in buying entire businesses...All of this points up the absurdity of the 'cash flow' numbers that are often set forth in Wall Street reports. These numbers routinely include (a) plus (b) - but do not subtract (c)."

Dr Lalchandani Labs's Price-to-Owner-Earnings for today is calculated as

Price-to-Owner-Earnings=Share Price/Owner Earnings per Share (TTM)
=20.15/-1.66
=

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.


Dr Lalchandani Labs  (BOM:541299) Price-to-Owner-Earnings Explanation

For how to get Owner Earnings per Share (TTM), please click.


Dr Lalchandani Labs Price-to-Owner-Earnings Related Terms

Thank you for viewing the detailed overview of Dr Lalchandani Labs's Price-to-Owner-Earnings provided by GuruFocus.com. Please click on the following links to see related term pages.


Dr Lalchandani Labs (BOM:541299) Business Description

Traded in Other Exchanges
N/A
Address
Greater Kailash, Part-1, M-20, Basement, South Delhi, New Delhi, IND, 110048
Dr Lalchandani Labs Ltd engages in the business of running laboratories for carrying out pathological investigations of various branches of biochemistry, hematology, histopathology, microbiology, electrophoresis, immunology, virology, cytology, and other pathological and radiological investigations. It also offers Immunoassay, Immuno-Histochemistry, Molecular Pathology, DNA, and Genetic Testing. The company operates in two segments B2B sales and B2C sales, out of which the majority is from B2C sales. Revenue is generated from the sale of services.

Dr Lalchandani Labs (BOM:541299) Headlines

No Headlines